Computer simulation of randomized cancer screening trials to compare methods of estimating lead time and benefit time

DOI10.1016/S0167-9473(96)00029-1MaRDI QIDQ672039zbMATH OpenFDO

Authors Karen Kafadar, Philip C. Prorok

Publication date 27 February 1997

Published in Computational Statistics and Data Analysis (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1016/S0167-9473(96)00029-1

zbMATH Keywords

Bivariate gamma densityCatch-up pointDisease progression modelIncidence rateSojourn timeSurvival timeTest sensitivity

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Probabilistic models, generic numerical methods in probability and statistics (65C20)

Recommendations

• An Estimate of the Variance of Estimators for Lead Time and Screening Benefit Time in Randomized Cancer Screening Trials
• A review of estimation of key parameters and lead time in cancer screening
• Bayesian Inference for the Lead Time in Periodic Cancer Screening
• A stochastic model for calibrating the survival benefit of screen-detected cancers

Cites work

• An age dependent stochastic model of periodic screening: Basic properties
• An age dependent stochastic model of periodic screening: Length bias at a prevalence screen
• An Estimate of the Variance of Estimators for Lead Time and Screening Benefit Time in Randomized Cancer Screening Trials
• scientific article; zbMATH DE number 3984308 (Why is no real title available?)
• scientific article; zbMATH DE number 3782216 (Why is no real title available?)
• On the theory of screening for chronic diseases
• Robust Statistics
• Screening for the early detection of cancer - I. The temporal natural history of a progressive disease state
• Simplified Models of Screening for Chronic Disease: Estimation Procedures from Mass Screening Programmes
• The theory of periodic screening I: Lead time and proportion detected

Cited in

(7)

• Estimating the difference in location parameters of two survival curves, with applications to cancer screening
• Estimating case-fatality reduction from randomized screening trials
• Quantification of length-bias in screening trials with covariate-dependent test sensitivity
• An Estimate of the Variance of Estimators for Lead Time and Screening Benefit Time in Randomized Cancer Screening Trials
• Estimating Lead Time and Sensitivity in a Screening Program without Estimating the Incidence in the Screened Group
• A stochastic model for calibrating the survival benefit of screen-detected cancers
• Bayesian Inference for the Lead Time in Periodic Cancer Screening

This page was built for publication: Computer simulation of randomized cancer screening trials to compare methods of estimating lead time and benefit time

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q672039)